Specimen X-Rays of Removed Axillary Lymph Nodes to Guide Pathological Sampling
NCT01156454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2016-12-23
Summary
X-ray mapping of sentinel lymph nodes and/or axillary tissue will assist pathologists in their ability to identify the number and location of lymph nodes as well as more accurately section lymph nodes contained in surgical specimens.
Conditions
Interventions
- PROCEDURE
-
X-ray
surgical specimen taken to radiology and contents x-rayed
Sponsors & Collaborators
-
Tenenbaum Family Foundation
collaborator OTHER -
University of Arkansas
lead OTHER
Principal Investigators
-
V. Suzanne Klimberg, MD · UAMS
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2011-01-31
- Completion
- 2012-01-31
Countries
- United States
Study Locations
More Related Trials
-
Lymphatic Mapping After Previous Breast Surgery
NCT01164748 ·Status: COMPLETED
-
Upper Extremity Lymphatic Mapping for Breast Cancer Patients
NCT00717886 ·Status: COMPLETED ·Phase: NA
-
Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients
NCT06780748 ·Status: RECRUITING ·Phase: PHASE2
-
Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients
NCT00952679 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Two Types of Biopsy in Suspicious Axillary Lymph Nodes
NCT03130946 ·Status: SUSPENDED ·Phase: NA
-
Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery
NCT00233974 ·Status: COMPLETED ·Phase: PHASE2
-
Sentinel Lymph Node Biopsy With or Without Para-Sentinel Lymph Node Dissection in Breast Cancer
NCT02651142 ·Status: UNKNOWN ·Phase: NA
-
Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease
NCT00312637 ·Status: WITHDRAWN ·Phase: NA
-
Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics
NCT05826197 ·Status: UNKNOWN
-
Axillary Radiotherapy for Early Stage Breast Cancer With Limited Positive Sentinel Lymph Nodes
NCT02612012 ·Status: UNKNOWN
-
Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients
NCT05703295 ·Status: UNKNOWN
-
Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer
NCT00005821 ·Status: UNKNOWN ·Phase: PHASE2
-
To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph Nodes
NCT03715686 ·Status: UNKNOWN ·Phase: NA
-
Identification of Sentinel Lymph Nodes Using Indocyanine Green in Breast Cancer Patients
NCT07311278 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection
NCT02610920 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Photoacoustic Lymph Node Imaging
NCT03931655 ·Status: TERMINATED
-
Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation Therapy
NCT01821768 ·Status: TERMINATED ·Phase: NA
-
Establishment and Clinical Application of Precise SLNB System in Breast Cancer: a Randomized, Multicenter, Controlled Study
NCT03857932 ·Status: RECRUITING ·Phase: NA
-
PET-MRI for Axillary Staging in Node Negative Breast Cancer Patients
NCT03374826 ·Status: RECRUITING ·Phase: NA
-
Predict the Risk of Axillary Metastases in Breast Cancer Patients With Axillary Ultrasound
NCT02992769 ·Status: UNKNOWN
-
Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI
NCT04826211 ·Status: COMPLETED ·Phase: NA
-
Simulated Screening Study for Breast Imaging
NCT01807754 ·Status: COMPLETED
-
Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity
NCT02994225 ·Status: COMPLETED ·Phase: NA
-
Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)
NCT00784849 ·Status: COMPLETED ·Phase: PHASE2
-
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
NCT00003854 ·Status: COMPLETED ·Phase: PHASE3